Market Tracker

10/24 6:05pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7567
Data as of Oct 24
 -0.0013 / -0.17%
Today’s Change
0.37
Today|||52-Week Range
1.85
+48.37%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.76
Today’s open0.77
Day’s range0.70 - 0.77
Volume520,907
Average volume (3 months)1,019,209
Market cap$135.1M
Dividend yield--
Data as of 3:51pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-90.48%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.81

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.09-1.28%
INNLInnocoll AG+0.39+5.96%
CRMECardiome Pharma Corp-0.21-2.47%
SYNSynthetic Biologics ...-0.19-10.73%
Data as of 4:00pm ET, 10/24/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts